US Broker Ratings

89bio, Inc. (ETNB) Stock Analysis: Exploring a 125% Potential Upside in Clinical-Stage Biotech

89bio, Inc. (NASDAQ: ETNB) is capturing the attention of investors with its promising pipeline in the biotechnology sector. This clinical-stage biopharmaceutical company, established in 2018 and..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unpacking a 282% Potential Upside

ImmunityBio, Inc. (NASDAQ: IBRX), a key player in the biotechnology sector, is garnering considerable attention from investors due to its robust growth potential and promising therapeutic..

Arcellx, Inc. (ACLX) Stock Analysis: Biotechnology Innovator with 44.55% Upside Potential

Arcellx, Inc. (NASDAQ: ACLX), a promising player in the biotechnology sector, is capturing the attention of investors with its innovative approach to immunotherapy. Operating out of..

U.S. Physical Therapy, Inc. (USPH) Investor Outlook: Unpacking a 33.97% Potential Upside

U.S. Physical Therapy, Inc. (NYSE: USPH) is carving a niche in the healthcare sector, specifically within the medical care facilities industry. Based in Houston, Texas, and..

Clover Health Investments, Corp (CLOV): Investor Outlook Highlights 21.67% Potential Upside

Clover Health Investments, Corp (CLOV) is a notable player in the healthcare sector, specifically within the healthcare plans industry. Based in Wilmington, Delaware, Clover Health focuses..

MannKind Corporation (MNKD) Stock Analysis: Exploring an 89.79% Potential Upside in Biotech Innovation

MannKind Corporation (NASDAQ: MNKD), a prominent player in the healthcare sector, focuses on the development and commercialization of therapeutic products for endocrine and orphan lung diseases...

GoodRx Holdings, Inc. (GDRX) Investor Outlook: Exploring a 31.89% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX) presents a compelling case for investors seeking opportunities in the healthcare sector, particularly within the health information services industry. With a..

Sotera Health Company (SHC) Stock Analysis: Navigating Growth in the Diagnostics & Research Sector

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector, specifically within the diagnostics and research industry, with a market capitalization of $4.58 billion. As..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Strong Buy Ratings and 28.88% Potential Upside for Investors

Kiniksa Pharmaceuticals, Ltd. (KNSA), a standout player in the healthcare sector, is making significant strides in the drug manufacturing industry with a focus on specialty and..

Apogee Therapeutics, Inc. (APGE) Investor Outlook: 157.84% Potential Upside in the Biotech Frontier

Apogee Therapeutics, Inc. (NASDAQ: APGE) is capturing the attention of investors with its robust pipeline in the biotechnology sector, aiming to address various inflammatory and immunology..

UFP Technologies, Inc. (UFPT) Stock Analysis: Unlocking a 68.46% Potential Upside

For investors seeking opportunities in the healthcare sector, UFP Technologies, Inc. (NASDAQ: UFPT) presents an intriguing prospect with a significant potential upside. With its focus on..

Acadia Healthcare (ACHC) Stock Analysis: A 31.56% Upside Amidst Healthcare Sector Volatility

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a pivotal player in the behavioral healthcare services landscape, offers a compelling narrative for investors navigating the complex healthcare sector...

Innoviva, Inc. (INVA) Stock Analysis: Unpacking a 115% Potential Upside in Biotech

Innoviva, Inc. (NASDAQ: INVA), a biopharmaceutical company, is making significant waves in the healthcare sector with its promising portfolio and strong market potential. With a market..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Exploring a Potential 117% Upside in the Biotech Sector

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is capturing the attention of investors with a compelling potential upside of 117.45%. As a specialized player in the biotechnology sector,..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Unlocking a Potential 126% Upside in Biotech Innovations

Celldex Therapeutics, Inc. (NASDAQ: CLDX) stands at the forefront of biopharmaceutical innovation, with a focus on therapeutic antibodies for severe inflammatory, allergic, and autoimmune diseases. As..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 53.53% Potential Upside in the Medical Device Industry

Investors looking for opportunities in the healthcare sector might want to pay close attention to Enovis Corporation (ENOV), a prominent player in the medical device industry...

AtriCure, Inc. (ATRC) Stock Analysis: Exploring a 33% Potential Upside Amid Strong Buy Ratings

AtriCure, Inc. (NASDAQ: ATRC), a key player in the healthcare sector specializing in medical instruments and supplies, presents a compelling case for investors seeking growth in..

Addus HomeCare Corporation (ADUS) Stock Analysis: Unpacking a 24% Upside Potential for Investors

Addus HomeCare Corporation (NASDAQ: ADUS), a prominent player in the healthcare sector with a focus on medical care facilities, is making waves in the investment community...

Warby Parker Inc. (WRBY) Stock Analysis: Navigating a Market Cap of $3.48 Billion with Robust Revenue Growth

Warby Parker Inc. (NYSE: WRBY) has carved out a unique niche in the competitive eyewear market by combining style with affordability. This innovative approach positions the..

Liquidia Corporation (LQDA) Stock Analysis: Unveiling a 60% Potential Upside in Biotech Innovation

For investors seeking to capitalize on the explosive growth potential within the biotechnology sector, Liquidia Corporation (NASDAQ: LQDA) offers a compelling opportunity. With a significant market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds